1. Home
  2. VNDA vs ITRG Comparison

VNDA vs ITRG Comparison

Compare VNDA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • ITRG
  • Stock Information
  • Founded
  • VNDA 2002
  • ITRG 1997
  • Country
  • VNDA United States
  • ITRG Canada
  • Employees
  • VNDA N/A
  • ITRG N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • ITRG Precious Metals
  • Sector
  • VNDA Health Care
  • ITRG Basic Materials
  • Exchange
  • VNDA Nasdaq
  • ITRG Nasdaq
  • Market Cap
  • VNDA 261.7M
  • ITRG 277.2M
  • IPO Year
  • VNDA 2006
  • ITRG N/A
  • Fundamental
  • Price
  • VNDA $4.78
  • ITRG $1.48
  • Analyst Decision
  • VNDA Strong Buy
  • ITRG Strong Buy
  • Analyst Count
  • VNDA 3
  • ITRG 1
  • Target Price
  • VNDA $15.33
  • ITRG $2.75
  • AVG Volume (30 Days)
  • VNDA 408.4K
  • ITRG 1.1M
  • Earning Date
  • VNDA 07-30-2025
  • ITRG 08-13-2025
  • Dividend Yield
  • VNDA N/A
  • ITRG N/A
  • EPS Growth
  • VNDA N/A
  • ITRG N/A
  • EPS
  • VNDA N/A
  • ITRG N/A
  • Revenue
  • VNDA $201,351,000.00
  • ITRG $87,375,000.00
  • Revenue This Year
  • VNDA $16.86
  • ITRG $746.16
  • Revenue Next Year
  • VNDA $39.78
  • ITRG N/A
  • P/E Ratio
  • VNDA N/A
  • ITRG N/A
  • Revenue Growth
  • VNDA 13.37
  • ITRG N/A
  • 52 Week Low
  • VNDA $3.81
  • ITRG $0.79
  • 52 Week High
  • VNDA $6.37
  • ITRG $1.95
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 53.88
  • ITRG 43.07
  • Support Level
  • VNDA $4.85
  • ITRG $1.44
  • Resistance Level
  • VNDA $5.12
  • ITRG $1.55
  • Average True Range (ATR)
  • VNDA 0.18
  • ITRG 0.08
  • MACD
  • VNDA 0.01
  • ITRG -0.01
  • Stochastic Oscillator
  • VNDA 54.05
  • ITRG 19.70

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: